Results 211 to 220 of about 4,730,453 (227)

Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study

Applied Neuropsychology Adult, 2021
Anat Achiron, Eyal Heled, Roy Aloni
exaly  

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

JAMA - Journal of the American Medical Association, 2012
Yinshan Zhao, Helen Tremlett, Mohammad Ehsanul Karim   +2 more
exaly  

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Multiple Sclerosis Journal, 2020
Catherine Taylor, Annette Wundes, Tjalf Ziemssen   +2 more
exaly  

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis

Multiple Sclerosis Journal, 2008
Arthur F. Kramer, Robert Motl
exaly  

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Therapeutic Advances in Neurological Disorders, 2018
Gavin Giovannoni, Per Soelberg Sørensen, Giancarlo Comi   +2 more
exaly  

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

New England Journal of Medicine, 2008
Emmanuelle Waubant, Annette M Langer-Gould, Amit Bar-or   +2 more
exaly  

Previous treatment influences fingolimod efficacy in relapsing–remitting multiple sclerosis: results from an observational study

Current Medical Research and Opinion, 2014
Paolo Immovilli, Erica Curti, Diana Ferraro   +2 more
exaly  

Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis

Multiple Sclerosis Journal, 2005
Daniel Altmann, Alan J. Thompson, Gareth J. Barker   +2 more
exaly  

Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

Autoimmunity Reviews, 2019
Chuan Qin, Long-Jun Wu, Zhouping Tang
exaly  

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

Lancet, The, 1998
George C. Ebers
exaly